{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:24:45Z","timestamp":1791473085486,"version":"4.3.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Iron deficiency is a prevalent comorbidity in patients with heart failure (HF) and is associated with adverse outcomes. Traditional markers such as ferritin and transferrin saturation may be misleading due to the confounding impact of systemic inflammation. This study aimed to develop and validate the Adjusted Ferritin Inflammation Index (AFII), a novel composite score integrating ferritin\/C-reactive protein (CRP) ratio and albumin levels, to improve mortality risk stratification in HF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 322 patients with HF and reduced or mildly reduced ejection fraction (HF with reduced ejection fraction: left ventricular ejection fraction \u226440%; HF with mildly reduced ejection fraction: left ventricular ejection fraction 41%\u201349%). Patients were evaluated for iron parameters between January 2017 and September 2023. Laboratory values (ferritin, CRP, and albumin) were obtained at admission for inpatients or at the first outpatient evaluation. Baseline characteristics were compared between survivors and deceased patients. Adjusted Ferritin Inflammation Index was derived using logistic regression and calculated as: AFII = (Albumin \u00d7 \u22120.168) + (Ferritin\/CRP \u00d7 \u22120.012) + 6.958. The score was log-transformed (Base 2), and the optimal cut-off (2.1) was determined via receiver-operating characteristic curve analysis. Mortality predictors were assessed using Cox regression, and survival differences were analysed with Kaplan\u2013Meier curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 41 months, 106 patients (32.9%) died. In multivariate Cox regression, AFII \u2265 2.1 independently predicted mortality (hazard ratio: 2.155; 95% confidence interval: 1.361\u20133.412; P = .001), along with New York Heart Association (NYHA) class, sodium, brain natriuretic peptide, and smoking. Ferritin and transferrin saturation were not associated with survival (P = .733 and P = .790, respectively). The AFII showed superior predictive performance [area under the curve (AUC): 0.713] compared with ferritin\/CRP (AUC: 0.438) and albumin (AUC: 0.694). Kaplan\u2013Meier analysis showed significantly reduced survival in patients with AFII \u2265 2.1 across the overall cohort (3-year survival: 54.9% vs 84.6%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adjusted Ferritin Inflammation Index is a novel inflammation-adjusted metric that independently predicts mortality in HF with reduced ejection fraction\/HF with mildly reduced ejection fraction patients and outperforms traditional iron markers. Its use may enhance risk stratification and inform future strategies for iron deficiency management in HF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eschf\/xvag028","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:19:03Z","timestamp":1768825143000},"source":"Crossref","is-referenced-by-count":2,"title":["The adjusted ferritin inflammation index: a novel metric for predicting mortality in heart failure with reduced and mildly reduced ejection fraction"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1875-2078","authenticated-orcid":false,"given":"\u00c7etin","family":"Alak","sequence":"first","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Bursa Uludag University , Bursa ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7891-0794","authenticated-orcid":false,"given":"\u015e\u00fckr\u00fc","family":"\u00c7iri\u015f","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gaziantep State Hospital , Gaziantep ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan Fatih","family":"Yurdalan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Bursa Uludag University , Bursa ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4991-9830","authenticated-orcid":false,"given":"Fazil \u00c7a\u011fr\u0131","family":"Hunutlu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University , Bursa ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2422-9363","authenticated-orcid":false,"given":"Zeynep","family":"Kumral","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Unye State Hospital , Ordu ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9031-9039","authenticated-orcid":false,"given":"Tunay","family":"\u015eent\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Bursa Uludag University , Bursa ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"2026022605165911700_xvag028-B1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026022605165911700_xvag028-B2","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026022605165911700_xvag028-B3","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026022605165911700_xvag028-B4","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"2026022605165911700_xvag028-B5","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"2026022605165911700_xvag028-B6","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1182\/blood.2021013472","article-title":"The role of iron in chronic inflammatory diseases: from mechanisms to treatment options in anaemia of inflammation","volume":"140","author":"Marques","year":"2022","journal-title":"Am Soc Hematol-Blood"},{"key":"2026022605165911700_xvag028-B7","doi-asserted-by":"publisher","first-page":"9394060","DOI":"10.1155\/2018\/9394060","article-title":"Limitations of Serum ferritin in diagnosing iron deficiency in inflammatory conditions","volume":"11","author":"Dignass","year":"2018","journal-title":"Int J Chronic Diseases"},{"key":"2026022605165911700_xvag028-B8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2026022605165911700_xvag028-B9","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"61","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026022605165911700_xvag028-B10","doi-asserted-by":"publisher","first-page":"e004519","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2026022605165911700_xvag028-B11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","volume":"25","author":"Graham","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026022605165911700_xvag028-B12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jjcc.2023.06.012","article-title":"Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: meta-analysis and trial sequential analysis of randomized clinical trials","volume":"83","author":"Bhatia","year":"2024","journal-title":"J Cardiol"},{"key":"2026022605165911700_xvag028-B13","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.jacc.2018.02.071","article-title":"B-Type Natriuretic peptide levels and mortality in patients with and without heart failure","volume":"71","author":"York","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026022605165911700_xvag028-B14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/ehf2.12548","article-title":"Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy","volume":"7","author":"Briongos-Figuero","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2026022605165911700_xvag028-B15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcvm.2022.1082845","article-title":"Relationship between serum sodium levels and all-cause mortality in congestive heart failure patients: a retrospective cohort study based on the Mimic-III database","volume":"13","author":"Peng","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026022605165911700_xvag028-B16","doi-asserted-by":"publisher","first-page":"17358","DOI":"10.1038\/s41598-021-96702-z","article-title":"Cardiac mechanics and incident ischemic stroke: the cardiovascular health study","volume":"11","author":"Kamel","year":"2021","journal-title":"Sci Rep"},{"key":"2026022605165911700_xvag028-B17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.18332\/tid\/116411","article-title":"Association between persistent smoking after a diagnosis of heart failure and adverse health outcomes: a systematic review and meta-analysis","volume":"18","author":"Son","year":"2020","journal-title":"Tob Induc Dis"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/advance-article-pdf\/doi\/10.1093\/eschf\/xvag028\/66483654\/xvag028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/13\/1\/xvag028\/66483654\/xvag028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/13\/1\/xvag028\/66483654\/xvag028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:17:02Z","timestamp":1772101022000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/doi\/10.1093\/eschf\/xvag028\/8431730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,21]]},"published-print":{"date-parts":[[2026,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/eschf\/xvag028","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,21]]},"article-number":"xvag028"}}